Tergooi

Blaricum, Netherlands
General hospital in Blaricum
Rijksstraatweg 1, 1261 AN Blaricum

About Tergooi


"Wij richten ons op de patiënten in de regio Gooi en Vechtstreek en zijn een regionaal ziekenhuis met een focus op acuut klinische zorg."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Tergooi


During the past decade, Tergooi conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases
2005-01-01
2012-12-01
Terminated
80
Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer
2004-03-01
2008-09-01
Unknown status
130
TRACT Study: Evaluation of the Value of Routine Thoraco-abdominal CT in Blunt Trauma Patients
2005-06-01
2008-12-01
Completed
1,000
Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis
2007-03-05
2009-05-09
Completed
204
Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy
2008-07-01
2012-12-01
Completed
20
The Effects of Blood Pressure Reduction on Cerebral Perfusion and Cognition in the Elderly Population
2009-09-01
2013-12-01
Unknown status
60
In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II
2013-09-01
2014-01-01
Completed
20
The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa
2013-10-01
2015-04-01
Completed
875

Rows per page:

1–30 of 30

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Tergooi" #1 sponsor was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials, followed by "Bayer" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tergooi" #1 collaborator was "Amsterdam UMC, location VUmc" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 2 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Tergooi


According to Clinical.Site data, the most researched conditions in "Tergooi" are "Coronary Artery Disease" (4 trials), "Heart Failure" (4 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Cardiovascular Disease" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "Tergooi" in a lesser frequency.

Clinical Trials Intervention Types at Tergooi


Most popular intervention types in "Tergooi" are "Drug" (15 trials), "Other" (6 trials), "Device" (4 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Empagliflozin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Abbott Laboratories Xience" (1 trials) and "Abiraterone" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Tergooi


The vast majority of trials in "Tergooi" are 24 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Tergooi


Currently, there are NaN active trials in "Tergooi". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Tergooi, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Tergooi, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status